The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1269
September 10, 2007
View Complete Issue         Table of Contents 2019 
Tinidazole (Tindamax) - A New Option for Treatment of Bacterial Vaginosis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Tinidazole (Tindamax) - A New Option for Treatment of Bacterial Vaginosis
September 10, 2007 (Issue: 1269)
Tinidazole (Tindamax - Mission Pharmacal), an oral antiprotozoal drug available in the US since 2004 for treatment of trichomoniasis, giardiasis, amebiasis and amebic liver abscess, was recently approved by the FDA for treatment of bacterial...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Tinidazole (Tindamax) - A New Option for Treatment of Bacterial Vaginosis
Article code: 1269a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.